Company intelligence / Profile preview

QSimulate

Boston, Massachusetts, United Statesqsimulate.com ↗

Ownership: Private
Development stage: Preclinical

Overview

QSimulate does not develop its own drugs but provides advanced quantum mechanics-based software platforms that accelerate drug discovery and lead optimization by generating high-quality molecular data to improve AI predictions. Their technologies are used by pharmaceutical companies to enhance the accuracy and speed of small molecule drug development. No clinical results as they do not have their own pipeline.

Modalities: Small molecule (enables discovery/optimization of small molecules via simulation)Data-driven drug discovery toolsAI-powered simulation platformsQuantum mechanics-based simulation technology
Industry: Drug Discovery Services

Partnerships

Japan Tobacco Inc. (strategic partnership to integrate quantum simulations with JT's AI-driven small molecule drug discovery technologies)

Beyond the preview

Go deeper on QSimulate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QSimulate.

Explore the full profile